Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee

Arthritis Research and Therapy

Volumn 14, Issue 5, 2012, Pages

  Maksymowych, Walter P ^a   Russell, Anthony S ^a   Chiu, Peter ^a   Yan, Alex ^a   Jones, Niall ^a   Clare, Tracey ^a   Lambert, Robert G W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CELECOXIB; CODEINE; DICLOFENAC; IBUPROFEN; NAPROXEN; PARACETAMOL; TRAMADOL; TUMOR NECROSIS FACTOR ALPHA; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ALLOPATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COLITIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; JOINT EFFUSION; JOINT STIFFNESS; KNEE FUNCTION; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; MAXIMUM TOLERATED DOSE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPEN STUDY; OUTCOME ASSESSMENT; PROTEIN TARGETING; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITY OSTEOARTHRITIS INDEX; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECTS; INFLAMMATION; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; TIME; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866904391     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4044     Document Type: Article

References (31)

1. Musculoskeletal Disorders such as Arthritis and Osteoporosis. , http://www.naca-ccnta.ca/vignette/vig69_e.htm#69
2. Malemud CJ. Cytokines as therapeutic targets for osteoarthritis. BioDrugs 2004, 18:23-35. 10.2165/00063030-200418010-00003, 14733605.
3. Abramson SB, Yazici Y. Biologics in development for rheumatoid arthritis: relevance to osteoarthritis. Adv Drug Del Rev 2006, 58:212-225.
4. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001, 44:1237-1247. 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F, 11407681.
5. Hill CL, Gale DG, Chaisson CE, Kazis L, Tottermann S, Gale ME, Felson DT. Knee effusions, popliteal cysts and synovial thickening: association with knee pain in those with and without osteoarthritis. J Rheumatol 2001, 28:1330-1337.
6. Hill CL, Hunter DJ, Niu J, Clancy M, Guermazi A, Genant H, Gale D, Grainger A, Conaghan P, Felson DT. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 2007, 66:1599-1603. 10.1136/ard.2006.067470, 2095318, 17491096.
7. Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 2005, 13:361-367. 10.1016/j.joca.2005.01.005, 15882559.
8. Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993, 52:870-875. 10.1136/ard.52.12.870, 1005218, 8311538.
9. Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003, 48:2173-2177. 10.1002/art.11094, 12905470.
10. Bondeson I, Blom AB, Wainwright S, Hughes C, Caterson B, van den Berg W. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010, 62:647-657.
11. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005, 52:128-135. 10.1002/art.20776, 15641080.
12. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley S, Mankin H, McShane DJ, Medsger T, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum 1986, 29:1039-1049. 10.1002/art.1780290816, 3741515.
13. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988, 15:1833-1840.
14. Heald AE, Fudman EJ, Anklesaria P, Mease PJ. Single-joint outcome measures: preliminary validation of patient-reported outcomes and physical examination. J Rheumatol 2010, 37:1042-1048. 10.3899/jrheum.090827, 20231202.
15. Pham T, Van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M, Simon L, Strand V, Woodworth T, Dougados M. OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004, 12:389-399. 10.1016/j.joca.2004.02.001, 15094138.
16. Felson DT, Chaisson CE, Hill CL, Totterman SM, Gale ME, Skinner KM, Kazis L, Gale DR. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001, 134:541-549.
17. Sowers MF, Hayes C, Jamadar D, Capul D, Lachance L, Jannausch M, Welch G. Magnetic resonance-detected subchondral bone marrow and cartilage defect characteristics associated with pain and x-ray-defined knee osteoarthritis. Osteoarthritis Cartilage 2003, 11:387-393. 10.1016/S1063-4584(03)00080-3, 12801478.
18. Hill CL, Gale D, Chaisson CE, Skinner K, Kazis L, Gale ME, Felson DT. Periarticular lesions detected on magnetic resonance imaging: prevalence in knees with and without symptoms. Arthritis Rheum 2003, 48:2836-2844. 10.1002/art.11254, 14558089.
19. Fernandez-Madrid F, Karvonen RL, Teitge RA, Miller PR, An T, Negendank WG. Synovial thickening detected by MR imaging in osteoarthritis of the knee confirmed by biopsy as synovitis. Mag Res Imaging 1995, 13:177-183.
20. Hill CL, Hunter DJ, Niu J, Clancy M, Guermazi A, Genant H, Gale D, Grainger A, Conaghan P, Felson DT. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 2007, 66:1599-1603. 10.1136/ard.2006.067470, 2095318, 17491096.
21. Ostergaard M, Stoltenberg M, Gideon P, Sorensen K, Hendriksen O, Lorenzen I. Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J Rheumatol 1996, 23:1151-1161.
22. Dieppe PA, Sathapatayavongs B, Jones HE, Bacon PA, Ring EF. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil 1980, 19:212-217. 10.1093/rheumatology/19.4.212, 7010511.
23. Raynauld JP, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J, Uthman I, Khy V, Tremblay JL, Bertrand C, Pelletier JP. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2003, 48:370-377. 10.1002/art.10777, 12571845.
24. Loeuille D, Chary-Valckenaere I, Goebel C, Rat AC, Blum A, Kiefer P. MRI evaluation of the synovial membrane after a single intraarticular injection of anakinra in 7 patients with osteoarthritis of the knee. Arthritis Rheum 2005, 9:S70.
25. Chevalier X, Goupille P, Beaulieu AD, Burch FX, Bensen WG, Conrozier T, Loeuille D, Kivitz AJ, Silver D, Appleton BE. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009, 61:344-352. 10.1002/art.24096, 19248129.
26. Magnano MD, Chakravarty EF, Broudy C, Chung L, Kelman A, Hillygus J, Genovese MC. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J Rheumatol 2007, 34:1323-1327.
27. Grunke M, Schulze-Koops H. Successful treatment of inflammatory knee osteoarthritis with tumor necrosis factor blockade. Ann Rheum Dis 2006, 65:555-556. 10.1136/ard.2006.053272, 1798087, 16531556.
28. Hunter DJ, Zhang Y, Niu J, Goggins J, Amin S, LaValley MP, Genant H, Gale D, Felson DT. Increase in bone marrow lesions associated with cartilage loss. Arthritis Rheum 2006, 54:1529-1535. 10.1002/art.21789, 16646037.
29. Bollet AJ. Edema of the bone marrow can cause pain in osteoarthritis and other diseases of bone and joints. Ann Intern Med 2001, 134:591-593.
30. Hayes CW, Jamadar DA, Welch GW, Jannausch ML, Lachance LL, Capul DC, Sowers MR. Osteoarthritis of the knee: comparison of MR imaging findings with radiographic severity measurements and pain in middle-aged women. Radiology 2005, 237:998-1007. 10.1148/radiol.2373041989, 16251398.
31. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006, 354:795-808. 10.1056/NEJMoa052771, 16495392.